Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas
- 1 April 2007
- journal article
- clinical trial
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 106 (4) , 660-666
- https://doi.org/10.3171/jns.2007.106.4.660
Abstract
Object The accurate diagnosis of World Health Organization Grades II and III gliomas is crucial for the effective treatment of patients with such lesions. Increased cell density and mitotic activity are histological features that distinguish Grade III from Grade II gliomas. Because increased cellular proliferation and density both contribute to the in vivo magnetic resonance (MR) spectroscopic peak corresponding to choline-containing compounds (Cho), the authors hypothesized that multivoxel MR spectroscopy might help identify the tumor regions with the most aggressive growth characteristics, which would be optimal locations for biopsy. They investigated the ability to use one or more MR spectroscopic parameters to predict the MIB-1 cell proliferation index (PI), the terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick-end labeling cell death index (DI), the cell density, and the ratio of proliferation to cell death (PI/DI) within different regions of the same tumor. Methods Patien...Keywords
This publication has 18 references indexed in Scilit:
- Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopyMagnetic Resonance in Medicine, 2003
- Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patientsJournal of Magnetic Resonance Imaging, 2002
- Correlation between Magnetic Resonance Spectroscopy Imaging and Image-guided Biopsies: Semiquantitative and Qualitative Histopathological Analyses of Patients with Untreated GliomaNeurosurgery, 2001
- An automated technique for the quantitative assessment of 3D-MRSI data from patients with gliomaJournal of Magnetic Resonance Imaging, 2001
- In vivo Proton Magnetic Resonance Spectroscopy of Brain TumorsStereotactic and Functional Neurosurgery, 2000
- Evaluation of metabolic heterogeneity in brain tumors using1H-chemical shift imaging methodNMR in Biomedicine, 1997
- Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter studyJournal of Neurosurgery, 1996
- Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectivesZeitschrift für Neurologie, 1996
- Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance.Radiology, 1992
- Membrane phospholipid degradation and protein kinase C for cell signallingNeuroscience Research, 1992